Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HBL-4 |
Target |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), PLK1 inhibitors(Polo like kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC41H49N9O9 |
InChIKeyQSDZWQSDYJSGFC-IDCGIGBZSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | 02 Jan 2020 |